ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726771 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726771; 2) Community: the network communities that were significantly associated with the response to NSC 726771; 3) Molecule: the relationships between components within communities and NSC 726771; 4) MDR: the compounds that were significantly associated with the NSC 726771.

NSC Compound Enrichment Correlation
NSC 702106 Null 0.00783051864107159 -0.30116561
NSC 719211 11-(4'-Iodobutylidene)-5,6-dihydro-2,3-dimethoxy-6-methyl-8,9-methylenedioxy-5-oxo-11H-indeno[1,2-c]isoquinoline 0.00783051864107159 0.65643019
NSC 720438 Null 0.00783051864107159 0.53111995
NSC 740648 5,6-Dihydro-6-(3-imidazolyl-1-propyl)-9-methoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0078305186410717 0.62535689
NSC 761814 3-(4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole 0.0078305186410717 0.32799893
NSC 9612 Benzo[a]phenazoxonium, 5-(benzylamino)-9-(diethylamino)-, chloride (8CI) 0.0078305186410717 0.16253182
NSC 107660 Actinomycin Pip T.beta. 0.00863223795880985 0.33160357
NSC 137679 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- 0.00863223795880985 0.3622142
NSC 353451 Mitozolomide 0.00863223795880985 0.43018546
NSC 616348 Irinotecan hydrochloride 0.00863223795880985 0.56300121
Total:45  Current:8    [First] [Prev] [Next] [Last]